FLNA
Filana Therapeutics
$0.90
+$0.01 (+1.01%)Jul 27, 2026
Key metrics
The numbers that frame FLNA today
- Market cap
- $43.48M
- P/E (TTM)
- -0.6
- EV / FCF
- 1.4
- ROIC
- 354%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.89
- 52wk High
- $4.98
Growth
Revenue and earnings trend for FLNA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FLNA
Is Filana Therapeutics a good buy?
No. Filana Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of FLNA?
Filana Therapeutics's market capitalization is $43.48M.
What is the P/E ratio for FLNA stock?
Filana Therapeutics's current P/E ratio is -0.6.
What is the 52-week high for FLNA stock?
The 52-week high for Filana Therapeutics is $4.98. The current close of $0.90 is 81.9% below that high.
What is the 52-week low for FLNA stock?
The 52-week low for Filana Therapeutics is $0.89. The current close of $0.90 is 1.1% above that low.
Does FLNA stock pay dividends?
Filana Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for FLNA?
Filana Therapeutics's Debt / Equity ratio is 0.